Global Free Press Release Submissions Site
The Janus Kinase (JAK) inhibitors market has displayed a swift growth in recent years, expanding from $20.19 billion in 2024 to a forecasted $23.76 billion in 2025, representing a compound …
Janus Kinase (JAK) Inhibitors Market to Surge to $47.82 Billion by 2029 Amid Rising Incidence of Autoimmune Diseases Read More
Overview and Scope Janus Kinase (JAK) inhibitors are a class of drugs that block the activity of Janus Kinase enzymes. Janus Kinase (JAK) inhibitors are used for chronic inflammatory diseases …
Janus Kinase (JAK) Inhibitors Market Size, Trends, Growth And Outlook By 2033 Read More
The Janus Kinase (JAK) Inhibitors Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, …
Global Janus Kinase (JAK) Inhibitors Market Size and Forecast 2024-2033|Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi SA Read More